If left untreated, HIV progressively weakens the immune system, leading to AIDS (Acquired Immune Deficiency Syndrome). Over time, the body becomes increasingly susceptible to a wide range of opportunistic infections and cancers that it would typically resist. These infections, such as certain types of pneumonia, tuberculosis, and Kaposi's sarcoma (a type of cancer), can be life-threatening. Additionally, HIV can affect various organs and systems, leading to complications like neurological disorders, wasting syndrome (extreme weight loss), and cardiovascular disease. The progression from HIV to AIDS without treatment can vary but usually occurs within 10 years. The introduction of effective antiretroviral therapy has significantly changed the course of HIV infection, turning what was once a fatal disease into a manageable chronic condition.

HIV cannot be transmitted through casual contact. This includes activities such as shaking hands, hugging, using the same toilet, sharing utensils, or through mosquito bites. HIV is primarily transmitted through certain body fluids, including blood, semen, vaginal fluids, and breast milk. The most common modes of transmission are through unprotected sexual intercourse with an infected person and sharing needles or syringes. Understanding the routes of transmission is crucial for both prevention and alleviating misconceptions and stigma surrounding the virus. It's also important to highlight that with effective antiretroviral therapy, the viral load in an HIV-positive individual can be reduced to undetectable levels, significantly reducing the risk of transmission.

The effectiveness of antiretroviral therapy (ART) in HIV patients is monitored through regular blood tests that measure two key parameters: the viral load and CD4+ T cell count. The viral load test measures the amount of HIV RNA in the blood, providing an indication of how actively the virus is replicating. The goal of ART is to suppress the viral load to undetectable levels, indicating that the virus is not actively replicating. The CD4+ T cell count reflects the health of the immune system; a rising count suggests that the immune system is recovering and strengthening. Regular monitoring is essential to ensure that the ART regimen remains effective, to adjust treatment if resistance develops, and to check for any side effects of the therapy. Monitoring these parameters helps in making informed decisions regarding the management of HIV infection and ensuring optimal patient outcomes.

The Enzyme-Linked Immunosorbent Assay (ELISA) test plays a crucial role in the detection of HIV. It is a widely used diagnostic tool that detects the presence of antibodies against HIV in the blood. When a person is infected with HIV, their immune system produces specific antibodies as a response. The ELISA test identifies these antibodies, indicating a potential HIV infection. Its significance lies in its sensitivity and specificity, making it an effective screening tool. Early detection of HIV is vital for timely initiation of antiretroviral therapy, which can significantly improve the prognosis and reduce the risk of transmission. However, it's important to note that there is a window period after initial infection during which these antibodies may not be present in detectable levels, potentially leading to false negatives.

The genetic variability of HIV is a significant factor in its persistence within the human body. HIV's replication process is prone to errors due to the lack of proofreading ability in its reverse transcriptase enzyme. This leads to a high mutation rate, resulting in numerous viral strains, some of which may be resistant to the body's immune response and antiretroviral drugs. This genetic variability complicates vaccine development and treatment, as the immune system continually confronts new, slightly altered versions of the virus. Additionally, the high mutation rate enables HIV to adapt quickly to selective pressures, such as immune responses or antiretroviral therapies, making it a moving target for treatment and prevention strategies. This aspect of HIV biology underscores the necessity for combination therapies and ongoing research into more effective treatment options.